Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis

PURPOSE: This study aimed to characterize the prescribing of dalfampridine extended release (D-ER) 10 mg tablet treatment in people with multiple sclerosis (MS). METHODS: A retrospective cohort study was performed using Medco pharmacy and medical claims. Medical claims were used to identify MS patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Jara, Michele, Sidovar, Matthew F, Henney, Herbert R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274131/
https://www.ncbi.nlm.nih.gov/pubmed/25565851
http://dx.doi.org/10.2147/TCRM.S75837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274131/
https://www.ncbi.nlm.nih.gov/pubmed/25565851
http://dx.doi.org/10.2147/TCRM.S75837

Ejemplares similares